Page 141 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

Subtheme 5.3 – Management plans after screening need to be well-designed to
achieve a desirable impact. The Government should listen to patients’ voices and
take potential chronic disease complications into consideration upon
designing follow-up management plans. In terms of the management scheme, the
Government should factor in the costs incurred for more invasive procedures, as
well as the possibility of patients presenting multiple medical conditions beyond
the scope of HDH. Stakeholders anticipated negative responses from the population if
not all treatment costs arising from the screened conditions are borne by the Government.

Stakeholders’ voices

Can you (physicians joining the Scheme) really see a patient just for the
designated chronic disease and ignore the other symptoms or requests,
and charge for other things that the patient requests? And if you are a
patient, will you actually do that? You will separate yourself into different
diseases?
Academic

“Don’t worry, your condition is minor, very stable.” Do they
(patients) accept this kind of explanation after you have
provided a screening for them? They might think about
themselves having some sort of disorders already.

Policymaker

The Government needs to think what the subsidy can cover
[for disease management]–from medications, blood tests
to management of chronic diseases. Some complication
screenings are also necessary. Diabetes is especially
complicated. The Government needs to think twice about
the extent of subsidy, and plans for the management we
cannot cover. For example, for screening on diabetes
complication, where can patients check for retinopathy?
Public service provider

139